Switch to:
Nivalis Therapeutics Inc (NAS:NVLS)
EV/EBITDA
-2.39 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Nivalis Therapeutics Inc's enterprise value is $33.78 Mil. Nivalis Therapeutics Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Mar. 2015 was $-14.10 Mil. Therefore, Nivalis Therapeutics Inc's EV/EBITDA ratio for today is -2.39.

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Nivalis Therapeutics Inc's stock price is $16.97. Nivalis Therapeutics Inc's earnings per share for the trailing twelve months (TTM) ended in Mar. 2015 was $-1.92. Therefore, Nivalis Therapeutics Inc's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Nivalis Therapeutics Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=33.779/-14.104
=-2.39

Nivalis Therapeutics Inc's current Enterprise Value is $33.78 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Nivalis Therapeutics Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Mar. 2015 was $-14.10 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Nivalis Therapeutics Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=16.97/-1.92
=

Nivalis Therapeutics Inc's share price for today is $16.97.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Nivalis Therapeutics Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Mar. 2015 was $-1.92.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Nivalis Therapeutics Inc Annual Data

Dec12Dec13Dec14
ev2ebitda 0.000.000.000.000.000.000.000.000.000.00

Nivalis Therapeutics Inc Semi-Annual Data

Dec12Dec13Dec14Mar15
ev2ebitda 0.000.000.000.000.000.000.000.000.000.00
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK